Page 47 - AN-4-4

Advanced Neurology Lipid metabolism and Parkinson’s disease

adult human brain. Nat Commun. 2024;15(1):4455. neurodegenerative lysosomal storage disease model. Nat
Commun. 2017;8:14612.
doi: 10.1038/s41467-024-48734-y
doi: 10.1038/ncomms14612
10. Yoon JH, Seo Y, Jo YS, et al. Brain lipidomics: From
functional landscape to clinical significance. Sci Adv. 21. Hu M, Li P, Wang C, et al. Parkinson’s disease-risk protein
2022;8(37):eadc9317. TMEM175 is a proton-activated proton channel in
lysosomes. Cell. 2022;185(13):2292-2308.e20.
doi: 10.1126/sciadv.adc9317
doi: 10.1016/j.cell.2022.05.021
11. Hussain G, Haseeb A, Azhar R, et al. Lipids as biomarkers of
brain disorders. Crit Rev Food Sci Nutr. 2020;60(3):351-374. 22. Jin H, Wang L, Shen Y, Mao C, Chen J, Liu C. Inflammation-
associated peripheral blood cells and serum lipid levels
doi: 10.1080/10408398.2018.1529653
are associated with Parkinson’s disease. Chin Med J (Engl).
12. Qin B, Fu Y, Raulin AC, et al. Lipid metabolism in health and 2023;136(5):621-622.
disease: Mechanistic and therapeutic insights for Parkinson’s
disease. Chin Med J. 2025;138(12):1411-1423. doi: 10.1097/CM9.0000000000002397
23. Ioannou MS, Jackson J, Sheu SH, et al. Neuron-astrocyte
doi: 10.1097/cm9.0000000000003627
metabolic coupling protects against activity-induced fatty
13. Pizzuto M, Pelegrin P. Cardiolipin in immune signaling and acid toxicity. Cell. 2019;177(6):1522-1535.e14.
cell death. Trends Cell Biol. 2020;30(11):892-903.
doi: 10.1016/j.cell.2019.04.001
doi: 10.1016/j.tcb.2020.09.004
24. Cantuti-Castelvetri L, Fitzner D, Bosch-Queralt M, et al.
14. Xiao M, Zhong H, Xia L, Tao Y, Yin H. Pathophysiology of Defective cholesterol clearance limits remyelination in the
mitochondrial lipid oxidation: Role of 4-hydroxynonenal aged central nervous system. Science. 2018;359(6376):684-688.
(4-HNE) and other bioactive lipids in mitochondria. Free doi: 10.1126/science.aan4183
Radic Biol Med. 2017;111:316-327.
25. Hamilton LK, Dufresne M, Joppé SE, et al. Aberrant lipid
doi: 10.1016/j.freeradbiomed.2017.04.363
metabolism in the forebrain niche suppresses adult neural
15. Parida PK, Marquez-Palencia M, Ghosh S, et al. Limiting stem cell proliferation in an animal model of Alzheimer’s
mitochondrial plasticity by targeting DRP1 induces disease. Cell Stem Cell. 2015;17(4):397-411.
metabolic reprogramming and reduces breast cancer brain doi: 10.1016/j.stem.2015.08.001
metastases. Nat Cancer. 2023;4(6):893-907.
26. Glajch KE, Moors TE, Chen Y, et al. Wild-type GBA1
doi: 10.1038/s43018-023-00563-6
increases the α-synuclein tetramer-monomer ratio,
16. Xiong X, Hasani S, Young LEA, et al. Activation of Drp1 reduces lipid-rich aggregates, and attenuates motor and
promotes fatty acids-induced metabolic reprograming to cognitive deficits in mice. Proc Natl Acad Sci U S A.
potentiate Wnt signaling in colon cancer. Cell Death Differ. 2021;118(31):e2103425118.
2022;29(10):1913-1927.
doi: 10.1073/pnas.2103425118
doi: 10.1038/s41418-022-00974-5
27. Paillusson S, Gomez-Suaga P, Stoica R, et al. α-Synuclein
17. Wedan RJ, Longenecker JZ, Nowinski SM. Mitochondrial binds to the ER-mitochondria tethering protein VAPB
fatty acid synthesis is an emergent central regulator to disrupt Ca homeostasis and mitochondrial ATP
2+
of mammalian oxidative metabolism. Cell Metab. production. Acta Neuropathol. 2017;134(1):129-149.
2024;36(1):36-47.
doi: 10.1007/s00401-017-1704-z
doi: 10.1016/j.cmet.2023.11.017
28. Zhang L, Zhou Y, Yang Z, et al. Lipid droplets in
18. Choi ML, Chappard A, Singh BP, et al. Pathological structural central nervous system and functional profiles of brain
conversion of α-synuclein at the mitochondria induces cells containing lipid droplets in various diseases.
neuronal toxicity. Nat Neurosci. 2022;25(9):1134-1148. J Neuroinflammation. 2025;22(1):7.
doi: 10.1038/s41593-022-01140-3 doi: 10.1186/s12974-025-03334-5
19. Conde MA, Alza NP, Iglesias González PA, et al. Phospholipase 29. Guardia-Laguarta C, Area-Gomez E, Rüb C, et al.
D1 downregulation by α-synuclein: Implications for α-Synuclein is localized to mitochondria-associated ER
neurodegeneration in Parkinson’s disease. Biochim Biophys membranes. J Neurosci. 2014;34(1):249-259.
Acta Mol Cell Biol Lipids. 2018;1863(6):639-650.
doi: 10.1523/JNEUROSCI.2507-13.2014
doi: 10.1016/j.bbalip.2018.03.006
30. Vanherle S, Loix M, Miron VE, Hendriks JJA, Bogie JFJ.
20. Bagh MB, Peng S, Chandra G, et al. Misrouting of v-ATPase Lipid metabolism, remodelling and intercellular transfer in
subunit V0a1 dysregulates lysosomal acidification in a the CNS. Nat Rev Neurosci. 2025;26(4):214-231.

Volume 4 Issue 4 (2025) 41 doi: 10.36922/AN025320086